Interestingly, expression of an NKG2A ligand, HLA-E expression, is associated with poor prognosis in pancreatic cancer.29 These results demonstrate the ability to use the co-culture platform to identify checkpoint inhibition strategies for effective immunotherapy. The gene discussed is HLA-E; the disease is pancreatic neoplasm.